UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009581
Receipt number R000011241
Scientific Title Lymphocyte subsets in myasthenica gravis
Date of disclosure of the study information 2013/01/30
Last modified on 2012/12/19 10:22:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Lymphocyte subsets in myasthenica gravis

Acronym

Lymphocyte subsets in myasthenica gravis

Scientific Title

Lymphocyte subsets in myasthenica gravis

Scientific Title:Acronym

Lymphocyte subsets in myasthenica gravis

Region

Japan


Condition

Condition

Myasthenia Gravis

Classification by specialty

Medicine in general Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the Analysis of myasthenia gravis, and to contribute to the establishment of appropriate treatment.

Basic objectives2

Others

Basic objectives -Others

To elucidate the analysis

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The MG-ADL score, the ratio of each lymphocyte subset, autoantibody titer, various blood cytokine at the time of the drawing blood

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Vein drawing blood

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The myasthenia gravis patient

Key exclusion criteria

The patient who refused this reseach

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akihiro Kubota

Organization

Saitama medical center, Saitama medical university

Division name

Neurology

Zip code


Address

1981 Kamoda, Kawagoe-shi, SAITAMA

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Saitama medical center, Saitama medical university

Division name

Neurology

Zip code


Address


TEL


Homepage URL


Email

midline@saitama-med.ac.jp


Sponsor or person

Institute

Neurology, Saitama medical center, Saitama medical university

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 01 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2012 Year 12 Month 25 Day

Date of IRB


Anticipated trial start date

2013 Year 02 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 12 Month 19 Day

Last modified on

2012 Year 12 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011241


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name